The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+–calcineurin–NFAT signaling pathway
Authors:
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 407 (4) , 807-812
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (5102040)
This publication has 32 references indexed in Scilit:
- Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokinesImmunology, 2011
- Monocyte migration: A novel effect and signaling pathways of catestatinEuropean Journal of Pharmacology, 2008
- The endocrine role for chromogranin A: A prohormone for peptides with regulatory propertiesCellular and Molecular Life Sciences, 2007
- Hypertension from targeted ablation of chromogranin A can be rescued by the human orthologJournal of Clinical Investigation, 2005
- The Chromogranin–Secretogranin FamilyNew England Journal of Medicine, 2003
- Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.Journal Of Hypertension, 2002
- Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivoPeptides, 1998
- Response of Vascular Smooth Muscle Cells to the Neuropeptide SecretoneurinArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cellsPeptides, 1993
- Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cellsBiochemical and Biophysical Research Communications, 1985